Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse Papenburg

Showing results (81-90 of 168) with videos related to

Pageof 17
Sort By:
JAMA Network Open|May 6, 2022
Adequacy of Serial Self-performed SARS-CoV-2 Rapid Antigen Detection Testing for Longitudinal Mass Screening in the WorkplaceJesse Papenburg, Jonathon R Campbell, Chelsea Caya, et al.
Preventive Medicine Reports|September 21, 2020
Effectiveness of palivizumab immunoprophylaxis to prevent respiratory syncytial virus hospitalizations in healthy full-term <6-month-old infants from the circumpolar region of Nunavik, Quebec, CanadaRodica Gilca, Marie-Noëlle Billard, Joseline Zafack, et al.
Clinical and Vaccine Immunology : CVI|January 14, 2011
Evaluation of serological diagnostic methods for the 2009 pandemic influenza A (H1N1) virusJesse Papenburg, Mariana Baz, Marie-Ève Hamelin, et al.
Human Vaccines & Immunotherapeutics|March 9, 2017
Viral interference and the live-attenuated intranasal influenza vaccine: Results from a pediatric cohort with cystic fibrosisConstantina Boikos, Jesse Papenburg, Christine Martineau, et al.
The Journal of Infectious Diseases|September 12, 2012
Presence of oseltamivir-resistant pandemic A/H1N1 minor variants before drug therapy with subsequent selection and transmissionElodie Ghedin, Edward C Holmes, Jay V DePasse, et al.
Open Forum Infectious Diseases|October 18, 2016
Influenza Virus Detection Following Administration of Live-Attenuated Intranasal Influenza Vaccine in Children With Cystic Fibrosis and Their Healthy SiblingsConstantina Boikos, Lawrence Joseph, Christine Martineau, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|May 14, 2026
AMMI Canada seasonal influenza guideline update 2025-26: Some questions answeredRobyn Harrison, Emma K Reid, Upton D Allen, et al.
Virology|August 5, 2023
In-vivo and human evidence for potential efficacy of therapeutic polyclonal RSV neutralizing antibodies for palivizumab-resistant RSV infectionsKacy A Ramirez, James Mond, Jesse Papenburg, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 18, 2013
Genetic diversity and molecular evolution of the major human metapneumovirus surface glycoproteins over a decadeJesse Papenburg, Julie Carbonneau, Sandra Isabel, et al.
Vaccine|August 5, 2017
Adverse events following live-attenuated intranasal influenza vaccination of children with cystic fibrosis: Results from two influenza seasonsConstantina Boikos, Lawrence Joseph, David Scheifele, et al.
Pageof 17

Showing results (81-90 of 168) with videos related to

Sort By:
Pageof 17
JAMA Network Open|May 6, 2022
Adequacy of Serial Self-performed SARS-CoV-2 Rapid Antigen Detection Testing for Longitudinal Mass Screening in the WorkplaceJesse Papenburg, Jonathon R Campbell, Chelsea Caya, et al.
Preventive Medicine Reports|September 21, 2020
Effectiveness of palivizumab immunoprophylaxis to prevent respiratory syncytial virus hospitalizations in healthy full-term <6-month-old infants from the circumpolar region of Nunavik, Quebec, CanadaRodica Gilca, Marie-Noëlle Billard, Joseline Zafack, et al.
Clinical and Vaccine Immunology : CVI|January 14, 2011
Evaluation of serological diagnostic methods for the 2009 pandemic influenza A (H1N1) virusJesse Papenburg, Mariana Baz, Marie-Ève Hamelin, et al.
Human Vaccines & Immunotherapeutics|March 9, 2017
Viral interference and the live-attenuated intranasal influenza vaccine: Results from a pediatric cohort with cystic fibrosisConstantina Boikos, Jesse Papenburg, Christine Martineau, et al.
The Journal of Infectious Diseases|September 12, 2012
Presence of oseltamivir-resistant pandemic A/H1N1 minor variants before drug therapy with subsequent selection and transmissionElodie Ghedin, Edward C Holmes, Jay V DePasse, et al.
Open Forum Infectious Diseases|October 18, 2016
Influenza Virus Detection Following Administration of Live-Attenuated Intranasal Influenza Vaccine in Children With Cystic Fibrosis and Their Healthy SiblingsConstantina Boikos, Lawrence Joseph, Christine Martineau, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|May 14, 2026
AMMI Canada seasonal influenza guideline update 2025-26: Some questions answeredRobyn Harrison, Emma K Reid, Upton D Allen, et al.
Virology|August 5, 2023
In-vivo and human evidence for potential efficacy of therapeutic polyclonal RSV neutralizing antibodies for palivizumab-resistant RSV infectionsKacy A Ramirez, James Mond, Jesse Papenburg, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 18, 2013
Genetic diversity and molecular evolution of the major human metapneumovirus surface glycoproteins over a decadeJesse Papenburg, Julie Carbonneau, Sandra Isabel, et al.
Vaccine|August 5, 2017
Adverse events following live-attenuated intranasal influenza vaccination of children with cystic fibrosis: Results from two influenza seasonsConstantina Boikos, Lawrence Joseph, David Scheifele, et al.
Pageof 17